TLR4 and myocardial ischemia: utilized PLGA nanoparticles to deliver TAK‐242, an inhibitor of the TLR4 intracellular domain, to attenuate TLR4‐mediated inflammation in myocardial ischemia‐reperfusion (IR) injury.[87] In a different approach, Zhao et al.